Marunaka Industries Co., Ltd.
Dashboard
Risk PXL 3.8

Unapproved second vendor (shadow IT) expands scope

#platform shows a MultiWorks sandbox trial without procurement sign-off; a 2-week investigation has run 3 weeks; no owner of record, no scope on the schedule.

NEURON ingested 312 items
Related risks:D1C1
Related signals:
Risk Score Breakdown
PXL Score
3.8
Probability95%
Impact80%
Goal
Controlled, approved vendor evaluation.
Change
Shadow trial → governed selection.
Trigger
Sandbox trial without sign-off.
Open items
Owner; security review.

Why this is a risk

  • No approval.
  • No owner.
  • Security review skipped.
  • Schedule unscoped.

Blast Radius & Consequences

What this risk touches, and what breaks if it goes unaddressed.

Teams affected
Procurement/IT
Customers affected
Expected delay
What's at stake
Scope control + security.
Worst case: Uncontrolled scope + vendor lock-in + security exposure.
Cascading risks
2

Other risks this could trigger or worsen if unresolved.

  • WorsensD1 (vendor decision)PXL 0
  • WorsensC1PXL 0

Recommended Solution

NEURON AI

Fold the trial into the formal vendor selection (D1); assign an owner; run security review.

Why this works

Mirrors the 2025 Q3 shadow-tool consolidation.

Similar past cases1
2025 Q3 shadow tool consolidation

Linked Board Items

1
#platform MultiWorks trial